Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Endocrinology
Volume 2017, Article ID 4709262, 6 pages
https://doi.org/10.1155/2017/4709262
Case Report

Asymptomatic Congenital Hyperinsulinism due to a Glucokinase-Activating Mutation, Treated as Adrenal Insufficiency for Twelve Years

Center for Diabetes, Endocrinology and Metabolism, Shizuoka General Hospital, No. 4-27-1, Kita-Ando, Aoi-ku, Shizuoka, Shizuoka 420-8527, Japan

Correspondence should be addressed to Takako Yonemoto; pj.ca.u-otoyk.phuk@iokakat

Received 15 November 2016; Accepted 21 December 2016; Published 9 January 2017

Academic Editor: John Broom

Copyright © 2017 Kae Morishita et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. A. Stanley, “Perspective on the genetics and diagnosis of congenital hyperinsulinism disorders,” Journal of Clinical Endocrinology and Metabolism, vol. 101, no. 3, pp. 815–826, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. P. M. Thomas, G. J. Cote, N. Wohllk et al., “Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy,” Science, vol. 268, no. 5209, pp. 426–429, 1995. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Thomas, Y. Ye, and E. Lightner, “Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy,” Human Molecular Genetics, vol. 5, no. 11, pp. 1809–1812, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Glaser, P. Kesavan, M. Heyman et al., “Familial hyperinsulinism caused by an activating glucokinase mutation,” New England Journal of Medicine, vol. 338, no. 4, pp. 226–230, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. C. A. Stanley, Y. K. Lieu, B. Y. L. Hsu et al., “Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene,” New England Journal of Medicine, vol. 338, no. 19, pp. 1352–1357, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Højlund, T. Hansen, M. Lajer et al., “A novel syndrome of autosomal-dominant hyperinsulinemic hypoglycemia linked to a mutation in the human insulin receptor gene,” Diabetes, vol. 53, no. 6, pp. 1592–1598, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. E. R. Pearson, S. F. Boj, A. M. Steele et al., “Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene,” PLoS Medicine, vol. 4, no. 4, article no. e118, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Otonkoski, H. Jiao, N. Kaminen-Ahola et al., “Physical exercise-induced hypoglycemia caused by failed silencing of monocarboxylate transporter 1 in pancreatic β cells,” The American Journal of Human Genetics, vol. 81, no. 3, pp. 467–474, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. D. D. Deleon and C. A. Stanley, Eds., Monogenic Hyperinsulinemic Hypoglycemia Disorders. Frontiers in Diabetes, Karger, Geneva, Swizerland, 2012.
  10. The Japan Endocrine Society, “Guideline of management and treatment of adrenal insufficiency,” 2014 (Japanese), http://square.umin.ac.jp/endocrine/hottopics/20140311sinryousisin.pdf.
  11. S. Sayed, D. R. Langdon, S. Odili et al., “Extremes of clinical and enzymatic phenotypes in children with hyperinsulinism caused by glucokinase activating mutations,” Diabetes, vol. 58, no. 6, pp. 1419–1427, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Meissner, J. Marquard, N. Cobo-Vuilleumier et al., “Diagnostic difficulties in glucokinase hyperinsulinism,” Hormone and Metabolic Research, vol. 41, no. 4, pp. 320–326, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Nanao, T. Yorifuji, T. Kamimaki et al., “Congenital hyperinsulinism in a Japanese family with a novel heterozygous GCK mutation,” Clinical Endocrinology, vol. 59, pp. 1049–1051, 2011 (Japanese). View at Google Scholar
  14. T. Yorifuji, M. Masue, and H. Nishibori, “Congenital hyperinsulinism: global and Japanese perspectives,” Pediatrics International, vol. 56, no. 4, pp. 467–476, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. K. K. Osbak, K. Colclough, C. Saint-Martin et al., “Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia,” Human Mutation, vol. 30, no. 11, pp. 1512–1526, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Marquard, A. A. Palladino, C. A. Stanley, E. Mayatepek, and T. Meissner, “Rare forms of congenital hyperinsulinism,” Seminars in Pediatric Surgery, vol. 20, no. 1, pp. 38–44, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. A. L. Cuesta-Muñoz, H. Huopio, T. Otonkoski et al., “Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation,” Diabetes, vol. 53, no. 8, pp. 2164–2168, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. P. E. Cryer, “Mechanisms of hypoglycemia-associated autonomic failure in diabetes,” New England Journal of Medicine, vol. 369, no. 4, pp. 362–372, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Mathur, J. Boparai, S. N. Mediwala et al., “Reversible Adrenal insufficiency in three patients with Post-Roux-en-Y gastric bypass noninsulinoma pancreatogenous hypoglycemia syndrome,” Journal of Investigative Medicine High Impact Case Reports, pp. 1–6, 2014. View at Publisher · View at Google Scholar
  20. L. Zhou, C.-Y. Yueh, D. D. Lam et al., “Glucokinase inhibitor glucosamine stimulates feeding and activates hypothalamic neuropeptide Y and orexin neurons,” Behavioural Brain Research, vol. 222, no. 1, pp. 274–278, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Zhou, D. S. Roane, X. Xi et al., “Short-term food restriction and refeeding alter expression of genes likely involved in brain glucosensing,” Experimental Biology and Medicine, vol. 228, no. 8, pp. 943–950, 2003. View at Google Scholar · View at Scopus
  22. S. Hahner and B. Allolio, “Management of adrenal insufficiency in different clinical settings,” Expert Opinion on Pharmacotherapy, vol. 6, no. 14, pp. 2407–2417, 2005. View at Publisher · View at Google Scholar · View at Scopus